Rechalange drug page Clinical trials

Trials with Rechalange

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
25Planned patients

Showing 1–1 of 1

A Study to Characterize Encorafenib Plus Cetuximab as Rechallenge Treatment for BRAF V600E-mutant Metastatic Colorectal Cancer Patients After Previous Therapy With BRAF Inhibitors-based Combinations
Recruiting Phase 2 25 patients NCT07178717

This is an open-label, unicentre, single-arm Phase 2 study of encorafenib and cetuximab as rechallenge treatment in patients with BRAF V600E-mutant metastatic colorectal cancer after previous therapy with BRAF inhibitors-based combinations…

Spain Oct 2025 – Aug 2028 Interventional
Combined with: BevacizumabEncorafenib

Where the recruiting trials are